Loading…
Biomea Fusion, Inc. is projected to rise to $1.39 by 2027, a +2% move from its current price of $1.36. BMEA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.30 | $1.36 | $1.42 | 0.00% |
| May 30 | $1.27 | $1.36 | $1.45 | +0.01% |
| May 31 | $1.26 | $1.36 | $1.47 | +0.01% |
| Jun 1 | $1.24 | $1.36 | $1.49 | +0.02% |
| Jun 2 | $1.23 | $1.36 | $1.51 | +0.02% |
| Jun 3 | $1.21 | $1.36 | $1.52 | +0.03% |
| Jun 4 | $1.20 | $1.36 | $1.54 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.20 | $1.36 | $1.54 | +0.03% |
| Week 2 | $1.14 | $1.36 | $1.62 | +0.07% |
| Week 3 | $1.10 | $1.36 | $1.68 | +0.10% |
| Week 4 | $1.07 | $1.36 | $1.74 | +0.13% |
| Week 5 | $1.04 | $1.36 | $1.79 | +0.17% |
| Week 6 | $1.01 | $1.36 | $1.84 | +0.20% |
| Week 7 | $0.9854 | $1.36 | $1.89 | +0.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Biomea Fusion, Inc. is a clinical-stage healthcare company focused on diabetes and obesity medicines. It concentrates on the discovery and development of oral drugs to treat patients with diabetes and obesity.
Biomea Fusion, Inc. (BMEA) operates in the Healthcare sector. It currently trades at $1.42 per share and has a market cap of $102.67M, with a rank of 4226 by market capitalization.
A major floor 55.4% below — a decisive break under it would weaken the trend.
The nearest floor, 10.3% below — buyers have tended to step in here.
The nearest ceiling, 62.5% above — a clean break opens room to run.
A major ceiling 90.2% above — clearing it would confirm fresh momentum.
Key BMEA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BMEA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.38 | Sell | $1.37 | Sell |
| MA 10 | $1.36 | Sell | $1.39 | Sell |
| MA 20 | $1.44 | Sell | $1.45 | Sell |
| MA 50 | $1.54 | Sell | $1.50 | Sell |
| MA 100 | $1.44 | Sell | $1.49 | Sell |
| MA 200 | $1.51 | Sell | $1.77 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.93 | Neutral |
| Stoch RSI (14) | 55.26 | Neutral |
| CCI (20) | -54.72 | Neutral |
| Williams %R (14) | -65.85 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -11.69 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 34.15 | Neutral |
| TRIX (15) | -0.64 | Sell |
| Awesome (5,34) | -0.25 | Sell |
| Ultimate (7,14,28) | 44.51 | Neutral |
| Momentum (10) | -0.22 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 1.42 | Sell |
| ADX (14) | 16.56 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50. The stock’s short-term averages show SMA50 at $1.54 and SMA200 at $1.51.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.09 | $1.36 | $1.79 | 0% | Neutral | |
| $1.03 | $1.39 | $2.03 | +2% | Neutral | |
| $0.9805 | $1.39 | $2.15 | +2% | Neutral | |
| $0.8976 | $1.33 | $2.14 | -2% | Neutral | |
| $1.26 | $1.94 | $3.24 | +43% | Bullish | |
| $1.39 | $2.22 | $3.82 | +64% | Bullish | |
| $1.23 | $2.03 | $3.59 | +50% | Bullish | |
| $1.25 | $2.14 | $3.88 | +58% | Bullish | |
| $1.10 | $1.94 | $3.60 | +43% | Bullish | |
| $1.19 | $2.16 | $4.08 | +59% | Bullish | |
| $1.32 | $2.79 | $5.75 | +105% | Bullish | |
| $2.87 | $6.37 | $14.66 | +369% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.09 | $1.36 | $1.62 | +0.00% |
| June 2026 | $1.19 | $1.42 | $1.74 | +4.07% |
| July 2026 | $1.13 | $1.37 | $1.72 | -3.49% |
| August 2026 | $1.06 | $1.30 | $1.66 | -5.07% |
| September 2026 | $1.07 | $1.33 | $1.72 | +2.38% |
| October 2026 | $1.08 | $1.35 | $1.78 | +1.87% |
| November 2026 | $1.04 | $1.31 | $1.74 | -3.32% |
| December 2026 | $1.05 | $1.33 | $1.79 | +1.85% |
Click any year to see its month-by-month BMEA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BMEA is projected to trade between $1.09 and $1.79, averaging $1.36 — a potential gain of 0% from today's $1.36. Price action looks broadly range-bound.
Biomea Fusion, Inc.'s 2027 outlook centres on $1.39, within a $1.03 to $2.03 range. That is up +2% on the projected 2026 average. That marks a +2% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BMEA could reach as high as $2.15, with a base case around $1.39 and support toward $0.9805 — roughly +2% from $1.36. Price action looks broadly range-bound.
Expect BMEA to range from $0.8976 to $2.14 through 2029. The $1.33 average target implies a -2% move from current prices. That is -4% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The BMEA price prediction for 2030 points to an average of $1.94 (low $1.26, high $3.24) — a potential gain of +43% on today's $1.36. Momentum favours further upside here.
In 2031, BMEA is projected to trade between $1.39 and $3.82, averaging $2.22 — a potential gain of +64% from today's $1.36. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Biomea Fusion, Inc.'s 2032 outlook centres on $2.03, within a $1.23 to $3.59 range. That is -9% versus the projected 2031 average. That marks a +50% change versus current levels. Momentum favours further upside here.
By 2033, BMEA could reach as high as $3.88, with a base case around $2.14 and support toward $1.25 — roughly +58% from $1.36. Buyers look set to stay in control over this stretch.
Expect BMEA to range from $1.10 to $3.60 through 2034. The $1.94 average target implies a +43% move from current prices. That is -9% versus the projected 2033 average. Momentum favours further upside here.
The BMEA price prediction for 2035 points to an average of $2.16 (low $1.19, high $4.08) — a potential gain of +59% on today's $1.36. Buyers look set to stay in control over this stretch.
In 2040, BMEA is projected to trade between $1.32 and $5.75, averaging $2.79 — a potential gain of +105% from today's $1.36. That is up +29% on the projected 2035 average. Momentum favours further upside here.
Biomea Fusion, Inc.'s 2050 outlook centres on $6.37, within a $2.87 to $14.66 range. That is up +129% on the projected 2040 average. That marks a +369% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BMEA today (≈ 735.294118 BMEA) could be worth
$4,685.18
+$3,685.18 (+369%) by 2050 · US Dollar
Based on the average projected BMEA price of $6.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMEAwould be worth at today's price.
$1,000 invested in BMEA on May 27, 2025 (≈ 704.225373 BMEA) would be worth
$957.75
-$42.25 (-4.2%) today · 0.96× · US Dollar
Based on a BMEA entry price of $1.42 vs. today's $1.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.33 | $1,022.56 | +2.3% |
| 1 month ago | $1.73 | $786.13 | -21.4% |
| 3 months ago | $1.45 | $937.93 | -6.2% |
| 6 months ago | $1.09 | $1,247.71 | +24.8% |
| 1 year ago | $1.42 | $957.75 | -4.2% |
| All time (5.0y) ago | $18.74 | $72.57 | -92.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BMEA forecast.
Our base-case forecast reaches $2.70 around 2040.
Implied market cap at $2.70: $195.21M
The multi-year forecast shows a bullish path beginning in 2030. The 2030 average price is $1.98 with a 39.3 (ROI) and a bullish sentiment. The 2040 average price is $2.70 with a 90.2 ROI and a bullish sentiment.
By 2050, the average price is projected to $6.38 with a 349.3 ROI and a bullish sentiment. These estimates illustrate meaningful upside potential over the long term, though near-term results may vary and are not guaranteed. A number of years in the forecast show continued bullish momentum, while earlier years show more modest or flat expectations.
Tap a question to reveal the answer.
2030 average price is $1.98, with a min of $1.26 and a max of $3.35; ROI 39.3; sentiment BULLISH.
The 2026–2029 period shows NEUTRAL sentiment, with 2026 average $1.42, 2027 average $1.43, 2028 average $1.40, and 2029 average $1.35. The forecast turns BULLISH from 2030 onward, indicating potential upside over the longer term.
Yes. The forecast lists a 2040 max of $5.70 and a 2050 max of $14.67, indicating potential to exceed $5 by 2040.
Current price is $1.42 and market cap is $102.67M.
The 30-day range runs from a low of $1.03 to a high of $1.96.
Biomea Fusion, Inc. Community Discussion
0Share your Biomea Fusion, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.